These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24830182)

  • 1. The Heffter Research Institute: past and hopeful future.
    Nichols DE
    J Psychoactive Drugs; 2014; 46(1):20-6. PubMed ID: 24830182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Applications of Classic Hallucinogens.
    Bogenschutz MP; Ross S
    Curr Top Behav Neurosci; 2018; 36():361-391. PubMed ID: 28512684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide.
    Smith DE; Raswyck GE; Davidson LD
    J Psychoactive Drugs; 2014; 46(1):3-10. PubMed ID: 24830180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
    Grob CS; Danforth AL; Chopra GS; Hagerty M; McKay CR; Halberstadt AL; Greer GR
    Arch Gen Psychiatry; 2011 Jan; 68(1):71-8. PubMed ID: 20819978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Therapeutic Effects of Psilocybin.
    Johnson MW; Griffiths RR
    Neurotherapeutics; 2017 Jul; 14(3):734-740. PubMed ID: 28585222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.
    Carhart-Harris RL; Goodwin GM
    Neuropsychopharmacology; 2017 Oct; 42(11):2105-2113. PubMed ID: 28443617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editor's introduction: psychedelic resurgence--research and therapeutic uses, past and present.
    Chambers T
    J Psychoactive Drugs; 2014; 46(1):1-2. PubMed ID: 24830179
    [No Abstract]   [Full Text] [Related]  

  • 9. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).
    Emerson A; Ponté L; Jerome L; Doblin R
    J Psychoactive Drugs; 2014; 46(1):27-36. PubMed ID: 24830183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Therapeutic Potential of Psilocybin.
    Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
    Molecules; 2021 May; 26(10):. PubMed ID: 34063505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Past and Future of Psychedelic Science: An Introduction to This Issue.
    Doblin RE; Christiansen M; Jerome L; Burge B
    J Psychoactive Drugs; 2019; 51(2):93-97. PubMed ID: 31132970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
    Ross S; Bossis A; Guss J; Agin-Liebes G; Malone T; Cohen B; Mennenga SE; Belser A; Kalliontzi K; Babb J; Su Z; Corby P; Schmidt BL
    J Psychopharmacol; 2016 Dec; 30(12):1165-1180. PubMed ID: 27909164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Jules Bordet Institute: past, present and future].
    Gompel C
    Rev Med Brux; 2006; 27(3):191-7. PubMed ID: 16894960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
    Bogenschutz MP; Forcehimes AA; Pommy JA; Wilcox CE; Barbosa PC; Strassman RJ
    J Psychopharmacol; 2015 Mar; 29(3):289-99. PubMed ID: 25586396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.
    Johnson MW; Griffiths RR; Hendricks PS; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():143-166. PubMed ID: 29753748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The 40th anniversary of the State Research Center of the Russian Federation--Institute for Medical and Biological Problems of Russian Academy of Sciences].
    Buravkova LB
    Fiziol Cheloveka; 2003; 29(5):5-10. PubMed ID: 14611078
    [No Abstract]   [Full Text] [Related]  

  • 18. [IKEM--professional, political and other circumstances of its founding and present development].
    Bartos V
    Cas Lek Cesk; 2011; 150(1):5-6. PubMed ID: 21404480
    [No Abstract]   [Full Text] [Related]  

  • 19. [Health research at the Mexican Social Security Institute, a historical review].
    ; Jáuregui-Renaud K
    Rev Med Inst Mex Seguro Soc; 2011; 49(5):575-9. PubMed ID: 22185863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with psilocybin: applications for patients with psychiatric disorders].
    Breeksema JJ; Koolen MHB; Somers M; Schoevers RA
    Ned Tijdschr Geneeskd; 2021 Jan; 165():. PubMed ID: 33560605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.